HomeIRIDEX

IRIDEX

MicroPulse Transscleral Laser Therapy Is Now Accepted in the EGS Guidelines (Presented December 12-13, 2020)

“We are very encouraged with the broadening recognition of MicroPulse TLT in the ophthalmic community,” said David Bruce, CEO, IRIDEX. “Inclusion in the EGS guidelines plus nine papers presented in the Society’s meeting shows the growing adoption of this effective non-incisional therapy for the management of glaucoma disease.”